HIGHLIGHTS
SUMMARY
Therapeutic plasma exchange (TPE) has become a well-established therapeutic procedure in neurological clinical practice for numerous pathological conditions. Guillain-Barre Syndrome (GBS), Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Neuromyelitis_Optica Spectrum Disorder (NMOSD), Myasthenia Gravis (MG) and Multiple Sclerosis (MS) are among the five most frequent neurological indications for TPE. They are among the most common immune-mediated disorders with indications for urgent TPE in the intensive care setting as well. A few studies and one review article indicate similarly, that the effectiveness of TPE may be also given with volumes below this recommendation (i . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.